Tech Company Financing Transactions
TauRx Pharmaceuticals Funding Round
Private investors participated in a $135 million funding round for TauRx Pharmaceuticals. The round closed on 10/9/2015.
Transaction Overview
Company Name
Announced On
10/9/2015
Transaction Type
Venture Equity
Amount
$135,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The additional investment has been provided through a combination of new investors and existing shareholders and will support our Phase 3 clinical trials program.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3 Shenton Way 21-04
Singapore City, 068805
Singapore
Singapore City, 068805
Singapore
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
TauRx Pharmaceuticals Ltd is a spin-out company from the University of Aberdeen, Scotland, and was established in Singapore in 2002 with the aim of developing new treatments and diagnostics for a range of neurodegenerative diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Claude Wischik
Chief Operating Officer
Timothy Earle
Chief Scientific Officer
Charles Harrington
Chief Technical Officer
John Storey
VP - Finance
Hwang Wei
Browse more venture capital transactions:
Prev: 10/9/2015: Meditope Biosciences venture capital transaction
Next: 10/9/2015: ITUS Networks venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs